Pediatrix Medical Group Inc
For the period ended May 9, 2024. Filed Mar 28, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 9, 2024 · Filed Mar 28, 2024
Contents
Elements of Pay
Our pay philosophy was supported by the following pay elements in our executive compensation program for 2023:
| Element | Form | Description |
|---|---|---|
| Base Salary | Cash (Fixed) | Provides a competitive level of pay that reflects the executive’s experience, role and responsibilities and performance. |
| Annual Bonus | Cash (Variable) | Based 80% on annual Adjusted Income from Operations performance and 20% on certain non-financial metrics. |
| Long-Term Incentives | Equity (Variable) | Comprised of 50% restricted stock that vests over three years (back end weighted) and 50% performance shares tied to the achievement of annual Adjusted EBITDA targets and a three-year ROIC modifier. Any performance shares earned will vest at the end of the full three-year period, which is a change made beginning in 2023 in response to shareholder feedback. |
In 2023, we adjusted the performance share aspect of our long-term incentives by issuing performance-based equity awards with threeone-year performance periods. New performance goals will be set at the beginning of each year and awards for which the performance goals have been met will vest at the end of the full three-year period. In addition, the performance shares are also subject to a three-year ROIC modifier that may adjust the final payout up or down by as much as 20%.
| 2024 Proxy Statement | 37 | Pediatrix Medical Group, Inc. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.